Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla

Objectives:To assess the relationship between MRI derived parameters (apparent diffusion coefficient (ADC) and T2 relaxation time) and tumor cellularity as determined from whole mounted radical prostatectomy specimens, for both prostatic carcinoma and normal peripheral zone tissue. Materials and Methods:Over a 16-month period, 20 patients (mean age: 61 years, range: 42–70 years) were prospectively recruited. Diffusion and T2 imaging were performed on a 3.0 Tesla scanner to enable subsequent ADC and T2 calculation. After radical retropubic prostatectomy specimens were whole-mounted and regions of interest (ROIs) drawn in areas of prostatic carcinoma and normal peripheral zone. Cell density was then determined using an adaptive histogram thresholding technique. Differences in tissue type were explored using the unpaired t test while the relationship between parameters was assessed using scatter-plots and the Pearson correlation coefficient. Results:Significant differences (P < 0.0001 in all cases) were noted between peripheral zone tissue and prostatic carcinoma in terms of ADC (1.88 ± 0.22 vs. 1.43 ± 0.19 × 10−3 mm2/s), T2 (142 ± 24 vs. 109 ± 20 milliseconds), and cell density (9.4% ± 3.0% vs. 19.8% ± 5.3%). A significant negative correlation with cell density was noted for both ADC (R = −0.695, P < 0.0001) and T2 (R = −0.505, P = 0.001). Trends for increased cell density, decreased ADC, and decreased T2 with increasing Gleason score were also noted. Conclusions:ADC and to a lesser extent T2 are good indicators of cell density. Because of the potential link with Gleason score, MRI derived parameters may have a prognostic role with regard to potential metastatic activity and tumor aggressiveness.

[1]  Deanna L Langer,et al.  Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.

[2]  G P Liney,et al.  Comparison of conventional single echo and multi‐echo sequences with a fast spin‐echo sequence for quantitative T2 mapping: Application to the prostate , 1996, Journal of magnetic resonance imaging : JMRI.

[3]  L. Turnbull,et al.  Diffusion‐weighted imaging of normal and malignant prostate tissue at 3.0T , 2006, Journal of magnetic resonance imaging : JMRI.

[4]  H. Dang,et al.  Prostate cancer detection: comparison of t2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined , 2008, Acta radiologica.

[5]  S. Kyriazi,et al.  Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection , 2007, Acta radiologica.

[6]  Takeo Ishigaki,et al.  Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.

[7]  Olav Haraldseth,et al.  Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging , 2000, Magnetic resonance in medicine.

[8]  J. Tworek,et al.  Stromal tumors of the jejunum and ileum. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[9]  Neil J Sebire,et al.  Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. , 2007, Radiology.

[10]  Peter Gibbs,et al.  Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.

[11]  Silvia D. Chang,et al.  Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathology , 2006, Journal of magnetic resonance imaging : JMRI.

[12]  K. Hosseinzadeh,et al.  Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue , 2004, Journal of magnetic resonance imaging : JMRI.

[13]  U. G. Dailey Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.

[14]  Ning-Yu An,et al.  Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[15]  Cher Heng Tan,et al.  Diffusion weighted imaging in prostate cancer , 2011, European Radiology.

[16]  Robert E Lenkinski,et al.  Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. , 2007, Radiology.

[17]  Clare Allen,et al.  How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.

[18]  William Wells,et al.  Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier. , 2003, Medical physics.

[19]  P. Pasqualetti,et al.  Enhancement patterns of prostate cancer in dynamic MRI , 2003, European Radiology.

[20]  Guglielmo Manenti,et al.  Diffusion Tensor Magnetic Resonance Imaging of Prostate Cancer , 2007, Investigative radiology.

[21]  E. Squillaci,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging , 2006, La radiologia medica.

[22]  L. Turnbull,et al.  Diffusion Imaging of the Prostate at 3.0 Tesla , 2006, Investigative radiology.

[23]  H. Shinmoto,et al.  Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.

[24]  B. Issa,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[25]  J. Nelson,et al.  Dynamics of prostate cancer cell invasion studied in vitro by NMR microscopy , 1999, Magnetic resonance in medicine.

[26]  J Kurhanewicz,et al.  The prostate: MR imaging and spectroscopy. Present and future. , 2000 .

[27]  H. Kuwano,et al.  Cell Density Modulates the Metastatic Aggressiveness of a Mouse Colon Cancer Cell Line, Colon 26 , 2005, Oncology.

[28]  Masoom A Haider,et al.  Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.

[29]  Toshinori Hirai,et al.  Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.

[30]  Yutaka Imai,et al.  Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer , 2008, Radiation Medicine.

[31]  E. Squillaci,et al.  Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T , 2008, La radiologia medica.

[32]  J Alfred Witjes,et al.  Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. , 2005, Radiology.